What is the clinical evidence from this study?

Study design: Review. Population: Myocardial ischaemia / Ischaemic heart disease. Intervention: Metabolic interventions (e.g., trimetazidine, carnitine, CPT-I inhibitors, PDH activators).

What question did this study set out to answer?

The research aims to explore how different metabolic substrates impact heart damage during ischaemia and recovery post-ischaemia.

February 1, 1997Cardiovascular ResearchOpen Access

Regulation of myocardial carbohydrate metabolism under normal and ischaemic conditions Potential for pharmacological interventions

View Full Paper

Ask AI

Bookmark

Key result

Metabolic interventions aimed at enhancing glucose utilisation and pyruvate oxidation at the expense of fatty acid oxidation represent a valid therapeutic approach for treating myocardial ischaemia.

Why the study?

Do metabolic interventions enhancing glucose utilisation improve outcomes in myocardial ischaemia?

Design

Review

Authors

WSWilliam C. StanleyGeneral Cardiology

Discussion

Member takes

Implication

Supports metabolic modulation in ischaemia; leaves open confirmation of clinical benefit in prospective trials.

Key Points

The research aims to explore how different metabolic substrates impact heart damage during ischaemia and recovery post-ischaemia.
Focus on pharmacological interventions to enhance glucose utilization during myocardial ischaemia.
Investigate agents that inhibit fatty acid oxidation or activate pyruvate dehydrogenase (PDH).
Assessment of metabolic targets and agent efficacy through advanced techniques.
Increased fatty acid oxidation worsens outcomes compared to glucose oxidation in ischaemic conditions.
Trimetazidine and carnitine show limited approval for angina treatment in Europe.
Further clinical trials are needed to assess the efficacy of other mentioned agents for cardiac ischaemia.

Structured PICO

Do metabolic interventions enhancing glucose utilisation improve outcomes in myocardial ischaemia?

Intervention

Pharmacological agents enhancing glucose utilisation and pyruvate oxidation at the expense of fatty acid oxidation (e.g., trimetazidine, carnitine)

Metabolic modulation to favor glucose oxidation over fatty acid oxidation represents a promising therapeutic strategy for ischemic heart disease.

Limitations

It is not yet clear which of these approaches offers the best treatment of cardiac ischaemia.
Large scale clinical trials with many of the mentioned agents have not been completed.

Cite This Study

William C. Stanley (1997) conducted a review in Myocardial ischaemia / Ischaemic heart disease. Metabolic interventions (e.g., trimetazidine, carnitine, CPT-I inhibitors, PDH activators) was evaluated. Metabolic interventions aimed at enhancing glucose utilisation and pyruvate oxidation at the expense of fatty acid oxidation represent a valid therapeutic approach for treating myocardial ischaemia.

synapsesocial.com/papers/6a0aafea48609dcc0aac95cb https://doi.org/10.1016/s0008-6363(96)00245-3

View Full Paper

Ask AI

Bookmark

Regulation of myocardial carbohydrate metabolism under normal and ischaemic conditions Potential for pharmacological interventions

Discussion

Member takes

Implication

Key Points

Structured PICO

Limitations

Cite This Study

Regulation of myocardial carbohydrate metabolism under normal and ischaemic conditions Potential for pharmacological interventions

Discussion

Member takes

Implication

Key Points

Structured PICO

Limitations

Cite This Study

Also Consider

Also Consider